Holocene Advisors
PBH icon

Holocene Advisors’s Prestige Consumer Healthcare PBH Stock Holding History

Holocene Advisors’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-7,497
Closed -$253K – 689
2018
Q1 		$253K Sell
7,497
-10,077
-57% -$387K 0.01% 437
2017
Q4 		$780K Buy
+17,574
New +$801K 0.02% 269

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Holocene Advisors's PBH Position: Q2 2018 in Review

Holocene Advisors sold out of Prestige Consumer Healthcare (PBH) in Q2 2018, closing a stake of 7,497 shares — an estimated $253K sold.

Holocene Advisors first reported a position in PBH in Q4 2017 and held it in 2 quarters. The position peaked at $780K in Q4 2017. 237 funds tracked by Wall St. Rank hold PBH as of Q2 2018.

  • Holocene Advisors reported no remaining Prestige Consumer Healthcare position as of Q2 2018 after selling out during the quarter.
  • Holocene Advisors sold 7,497 Prestige Consumer Healthcare shares in Q2 2018, an estimated $253K.
  • Holocene Advisors first reported a position in Prestige Consumer Healthcare in Q4 2017 and held it in 2 quarters.
  • Holocene Advisors's Prestige Consumer Healthcare position peaked at $780K in Q4 2017.
  • 237 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2018.

Based on Holocene Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.